Last reviewed · How we verify
morphine ketamine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
morphine ketamine (morphine ketamine) — Tel-Aviv Sourasky Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| morphine ketamine TARGET | morphine ketamine | Tel-Aviv Sourasky Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- morphine ketamine CI watch — RSS
- morphine ketamine CI watch — Atom
- morphine ketamine CI watch — JSON
- morphine ketamine alone — RSS
Cite this brief
Drug Landscape (2026). morphine ketamine — Competitive Intelligence Brief. https://druglandscape.com/ci/morphine-ketamine. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab